company

FLEXIPHARMA AS

1540 VESTBY

Return on Equity
−50,22 %
Current Ratio
1,73
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue192 000
Net Income−231 000
Total Assets1 084 000
Total Equity460 000
Income (NOK)2022
Revenue192 000
Expenditure70 000
Operating Profit123 000
Financial Income906 000
Financial Costs1 256 000
Financial Balance−350 000
Earnings Before Tax−228 000
Tax3 000
Net Income−231 000
Balance (NOK)2022
Total Fixed Assets0
Total Current Assets1 084 000
Total Assets1 084 000
Total Retained Equity360 000
Total Equity460 000
Total Long-Term Debt0
Total Current Debt625 000
Total Equity and Debt1 084 000
Cash flow (NOK)2022
Sales Income192 000
Other Income0
Revenue192 000
Cost of Goods Sold0
Salary Costs0
Depreciation0
Impairment0
Expenditure70 000
Operating Profit123 000
Financial Income906 000
Financial Costs1 256 000
Financial Balance−350 000
Dividends0
Net Income−231 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock0
Total Investments393 000
Cash, Bank662 000
Total Current Assets1 084 000
Total Assets1 084 000
Total Equity460 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors15 000
Unpaid Taxes−1 000
Dividends0
Other Current Debt607 000
Total Current Debt625 000
Total Equity and Debt1 084 000
Financial indicators2022
Return on Equity−50,22 %
Debt-to-Equity Ratio0
Operating Profit Margin64,06 %
Current Ratio1,73
Quick Ratio1,73
Equity Ratio0,42
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English